Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer

BACKGROUND: Sarcopenia characterized by skeletal muscle loss may influence postoperative outcomes through physical decline and weakened immunity. We aimed to investigate clinical significance of sarcopenia in resected early-stage non-small cell lung cancer (NSCLC). METHODS: We retrospectively review...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Yusuke, Suzuki, Shigeki, Hamada, Kenichi, Nakada, Takeo, Oya, Yuko, Sakakura, Noriaki, Matsushita, Hirokazu, Kuroda, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944314/
https://www.ncbi.nlm.nih.gov/pubmed/33708952
http://dx.doi.org/10.21037/atm-20-4380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944314/
https://www.ncbi.nlm.nih.gov/pubmed/33708952
http://dx.doi.org/10.21037/atm-20-4380

Ejemplares similares